Skip to main content
logo
Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
2.040
+0.070 (3.55%)
At close: Sep 8, 2026, 4:00 PM EDT
2.000
-0.040 (-1.96%)
After-hours: Sep 8, 2026, 8:00 PM EDT

Regentis Biomaterials Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1135----
Market Cap Growth
------
Enterprise Value
478----
Last Close Price
2.046.74----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.237.36----
P/TBV Ratio
2.237.36----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.250.25-0.82-0.70-0.80-0.94
Net Debt / Equity Ratio
-1.30-1.30-0.78-0.67-0.65-0.51
Quick Ratio
2.652.650.050.110.141.02
Current Ratio
2.652.650.070.120.191.14
Return on Assets (ROA)
-107.53%-107.53%138.36%-116.21%-36.40%-18.55%
Return on Capital Employed (ROCE)
-146.90%-146.90%-15.50%69.50%19.10%-170.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-129.59%-39.10%----
Buyback Yield / Dilution
-249.41%-249.41%6.52%-6.97%--
SEC Filings: 10-K · 10-Q